Australia - engelsk - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - cod-liver oil, quantity: 1 g (equivalent: vitamin a, qty 300 re; equivalent: colecalciferol, qty 2.5 microgram) - capsule, soft - excipient ingredients: d-alpha-tocopherol; soya oil; gelatin; glycerol; purified water - maintain/support healthy eye function ; maintain/support eye health ; maintain/support healthy eyesight/vision ; maintain/support body mucous membrane health ; maintain/support general health and wellbeing ; maintain/support bone health ; maintain/support bone strength ; help maintain/support bone mineralisation ; maintain/support healthy cardiovascular system function ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support muscle function ; maintain/support healthy neuromuscular system/function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; maintain/support skin health ; maintain/support skin integrity/structure

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

rn labs pty ltd - cod-liver oil, quantity: 1.05 g (equivalent: eicosapentaenoic acid, qty 85 mg; equivalent: docosahexaenoic acid, qty 120 mg; equivalent: vitamin a, qty 9 re; equivalent: colecalciferol, qty 0.0025 microgram) - capsule, soft - excipient ingredients: lemon oil; rosemary oil; glycerol; purified water; gelatin; sunflower oil; mixed (high-alpha type) tocopherols concentrate - maintain/support general health and wellbeing

USA - engelsk - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 5 mg - oxycodone hydrochloride and acetaminophen tablets is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve oxycodone hydrochloride and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] oxycodone hydrochloride and acetaminophen tablets is contraindicated in patients with: controlled substance oxycodone hydrochloride and acetaminophen tablets n contain oxycodone, a schedule ii controlled substance. abuse oxycodone hydrochloride and acetaminophen tablets contains oxycodone, a substance with a high potential for abuse similar to other opioids including fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxymorphone, and tapentadol. oxycodone hydrochloride and acetaminophen tablets can be abused and is subject to misuse

USA - engelsk - NLM (National Library of Medicine)

mayne pharma inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 2.5 mg - oxycodone and acetaminophen tablets is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings], reserve oxycodone and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia oxycodone and acetaminophen tablets is contraindicated in patients with: - significant respiratory depression [see warnings] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings] - hypersensitivity to oxycodone, acetaminophen, or any other component of the product (e.g., anaphylaxis) [see warn

USA - engelsk - NLM (National Library of Medicine)

precision dose, inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 5 mg - oxycodone and acetaminophen tablets is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve oxycodone and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia oxycodone and acetaminophen tablets is contraindicated in patients with: - significant respiratory depression [see warnings ] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings ] hypersensitivity to oxycodone, acetaminophen, or any other component of the product (e.g., anaphylaxis) [see wa

USA - engelsk - NLM (National Library of Medicine)

actavis pharma, inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 2.5 mg - oxycodone and acetaminophen tablets, usp are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve oxycodone and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia oxycodone and acetaminophen tablets are contraindicated in patients with:  - significant respiratory depression [see warnings ] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings ] - hypersensitivity to oxycodone, acetaminophen, or any other component of the produc

USA - engelsk - NLM (National Library of Medicine)

par pharmaceutical - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 5 mg - oxycodone hydrochloride and acetaminophen tablets is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve oxycodone hydrochloride and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia oxycodone hydrochloride and acetaminophen tablets is contraindicated in patients with: - significant respiratory depression [see warnings ] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings ] - hypersensitivity to oxycodone, acetaminophen

USA - engelsk - NLM (National Library of Medicine)

bryant ranch prepack - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 10 mg - oxycodone hydrochloride and acetaminophen tablets is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve oxycodone hydrochloride and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] oxycodone hydrochloride and acetaminophen tablets is contraindicated in patients with: controlled substance oxycodone hydrochloride and acetaminophen tablets n contain oxycodone, a schedule ii controlled substance. abuse oxycodone hydrochloride and acetaminophen tablets contains oxycodone, a substance with a high potential for abuse similar to other opioids including fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxymorphone, and tapentadol. oxycodone hydrochloride and acetaminophen tablets can be abused and is subject to misus

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

jbx pty ltd - d-alpha-tocopherol, quantity: 4.35 mg; natural fish oil, quantity: 120 mg (equivalent: docosahexaenoic acid, qty 14.4 mg; equivalent: eicosapentaenoic acid, qty 21.6 mg); cod-liver oil, quantity: 275 mg (equivalent: vitamin a, qty 100 re; equivalent: colecalciferol, qty 0.75 microgram) - capsule, soft - excipient ingredients: purified water; soya oil; gelatin; glycerol - maintain/support healthy growth and development

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

star combo australia pty ltd - natural fish oil, quantity: 120 mg (equivalent: eicosapentaenoic acid, qty 21.6 mg; equivalent: docosahexaenoic acid, qty 14.4 mg); cod-liver oil, quantity: 275 mg (equivalent: vitamin a, qty 100 re/microgram; equivalent: colecalciferol, qty 0.75 microgram) - capsule, soft - excipient ingredients: - helps maintain/support healthy eye development ; maintain/support healthy eye function ; maintain/support general health and wellbeing ; helps enhance/promote bone health ; maintain/support healthy immune system function ; helps enhance/promote skin health